BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1937413)

  • 21. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
    Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
    Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of single and combined clinical characteristics for the diagnosis of dysplastic naevi.
    Maiweg C; Gartmann H; Lippold A; Balkau D; Wischer W; Suter L
    Melanoma Res; 1992; 1(5-6):377-83. PubMed ID: 1422193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-cytophotometry of benign compound and intradermal naevi, Spitz epithelioid naevi and malignant melanomas.
    Lindholm C; Bjelkenkrantz K; Hofer PA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(4):257-8. PubMed ID: 2890239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
    Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
    Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
    Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
    Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy as a driver for melanoma.
    Richtig G; Byrom L; Kupsa R; Schaider H; Hofmann-Wellenhof R; Wolf IH; Soyer HP; Richtig E
    Br J Dermatol; 2017 Sep; 177(3):854-857. PubMed ID: 27718538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
    Tóth-Molnár E; Hammer H; Oláh J
    Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Massively parallel sequencing analysis of benign melanocytic naevi.
    Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
    Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysplastic naevi in a population-based survey.
    Cooke KR; Spears GF; Elder DE; Greene MH
    Cancer; 1989 Mar; 63(6):1240-4. PubMed ID: 2917325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra].
    Bergman W; van Voorst Vader PC; Ruiter DJ
    Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2010-4. PubMed ID: 9550752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation.
    Fox C; Lambie D; Wilmott JS; Pinder A; Pavey S; Lê Cao KA; Akalin T; Karaarslan IK; Ozdemir F; Scolyer RA; Yamada M; Soyer HP; Schaider H; Gabrielli B
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):444-52. PubMed ID: 27166757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow and video-imaging cytometry--usefulness of DNA ploidy measurements in diagnosis of malignant melanoma.
    Skowronek J; Karaś Z; Krenz RM; Warchoł JB
    Adv Exp Med Biol; 2001; 495():435-8. PubMed ID: 11774606
    [No Abstract]   [Full Text] [Related]  

  • 33. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
    Szekeres L; Korom I
    Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of familial and non-familial melanoma in Australia.
    Ang CG; Kelly JW; Fritschi L; Dowling JP
    Melanoma Res; 1998 Oct; 8(5):459-64. PubMed ID: 9835460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular pigmented findings in patients with dysplastic naevus syndrome.
    Toth-Molnar E; Olah J; Dobozy A; Hammer H
    Melanoma Res; 2004 Feb; 14(1):43-7. PubMed ID: 15091193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subungual pigmented nevus: evaluation of DNA ploidy in six cases.
    Asahina A; Chi HI; Otsuka F
    J Dermatol; 1993 Aug; 20(8):466-72. PubMed ID: 8245307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis.
    Burroni M; Sbano P; Cevenini G; Risulo M; Dell'eva G; Barbini P; Miracco C; Fimiani M; Andreassi L; Rubegni P
    Br J Dermatol; 2005 Apr; 152(4):679-84. PubMed ID: 15840098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nevus on nevus. Apropos of 7 case reports, 3 of them associated with other dysplasias, and 1 with an invasive malignant melanoma].
    Brufau C; Moran M; Armijo M
    Ann Dermatol Venereol; 1986; 113(5):409-18. PubMed ID: 3579111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
    Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
    Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.